Recurrence of Hepatocellular Carcinoma in Noncirrhotic Liver After Hepatectomy
Author:
Publisher
Springer Science and Business Media LLC
Subject
Surgery
Link
http://link.springer.com/content/pdf/10.1007/s00268-013-2127-1.pdf
Reference18 articles.
1. Sherman M (2005) Hepatocellular carcinoma: epidemiology, risk factors and screening. Semin Liver Dis 25:143–154
2. Altekruse SF, McGlynn KA, Reichman ME (2009) Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 27:1485–1491
3. Xu L, Huang L, Li B (2008) Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver. Dig Surg 25:376–382
4. Borie F, Bouvier AM, Herrero A et al (2008) Treatment and prognosis of hepatocellular carcinoma: a population based study in France. J Surg Oncol 98:505–509
5. Laurent C, Blanc JF, Nobili S et al (2005) Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from non cirrhotic liver. J Am Coll Surg 201:656–662
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Successful multimodal management of a large hepatocellular carcinoma in a non-cirrhotic liver: a case report;Acta Chirurgica Belgica;2023-07-23
2. Evolving thresholds for liver transplantation in hepatocellular carcinoma: A Western experience;Annals of Gastroenterological Surgery;2020-02-11
3. Surgical treatment results of hepatocellular carcinoma in non‐cirrhotic liver in southern Chile: case series with follow‐up;ANZ Journal of Surgery;2019-09-30
4. Survival benefit of higher fraction dose delivered by three-dimensional conformal radiotherapy in hepatocellular carcinoma smaller than 10 cm in size;Cancer Management and Research;2019-04
Survival benefit of higher fraction dose delivered by three-dimensional conformal radiotherapy in hepatocellular carcinoma smaller than 10 cm in size
5. Treatment strategies for locally advanced hepatocellular carcinoma;Translational Gastroenterology and Hepatology;2019-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3